5-(N,N-dimethyl)-Amiloride Hydrochloride: Precision NHE1 Inhibition for Intracellular pH and Cardiovascular Research

Executive Summary: 5-(N,N-dimethyl)-Amiloride (hydrochloride), also known as DMA, is a highly selective inhibitor of Na+/H+ exchanger isoforms NHE1, NHE2, and NHE3, with Ki values of 0.02, 0.25, and 14 μM, respectively [APExBIO]. DMA is used to probe mechanisms of intracellular pH regulation and sodium ion transport in mammalian cells [Chen et al. 2021]. It is the gold-standard tool for studying cardiac ischemia-reperfusion injury due to its ability to normalize tissue sodium levels and prevent contractile dysfunction. Unlike less selective inhibitors, DMA has minimal effect on NHE4, NHE5, and NHE7, supporting accurate mechanistic studies. As a crystalline hydrochloride salt, DMA is soluble up to 30 mg/ml in DMSO or DMF, but solutions should be freshly prepared for optimal activity.

Biological Rationale

The Na+/H+ exchanger (NHE) family consists of membrane proteins that regulate intracellular pH and cell volume by exchanging intracellular protons (H+) for extracellular sodium ions (Na+). NHE1 is ubiquitously expressed in mammalian tissues, particularly in cardiovascular and endothelial cells, where it maintains pH homeostasis and supports cell survival under stress conditions [Chen et al. 2021]. Dysregulation of NHE1 and related isoforms is implicated in pathological processes such as ischemia-reperfusion injury, cardiac contractile dysfunction, and endothelial barrier disruption [Related Article]. The precise inhibition of these exchangers enables researchers to dissect their roles in disease models and to develop targeted therapeutic strategies.

Mechanism of Action of 5-(N,N-dimethyl)-Amiloride (hydrochloride)

DMA acts as a competitive inhibitor at the Na+ binding site of NHE isoforms. Its affinity is highest for NHE1 (Ki = 0.02 μM), followed by NHE2 (0.25 μM) and NHE3 (14 μM) [APExBIO]. By blocking Na+ influx and H+ efflux, DMA impairs the cell’s ability to recover from acid loads and to regulate cell volume, leading to measurable changes in intracellular pH and ion content. The compound’s specificity profile allows selective interrogation of NHE1-mediated processes without substantial off-target inhibition of other NHE isoforms such as NHE4, NHE5, and NHE7 [Related Article]. At the tissue level, DMA’s inhibition of Na+/H+ exchange attenuates sodium overload and reduces metabolic stress during ischemic episodes, as demonstrated in cardiac and hepatic models.

Evidence & Benchmarks

• DMA inhibits NHE1 with a Ki of 0.02 μM, NHE2 at 0.25 μM, and NHE3 at 14 μM, supporting its selectivity for NHE1-mediated processes (APExBIO).
• In rat cardiac tissue, DMA prevents sodium overload and preserves contractile function during ischemia-reperfusion injury (Chen et al. 2021).
• DMA inhibits ouabain-sensitive ATP hydrolysis and sodium-potassium ATPase in rat liver plasma membranes, demonstrating impact on broader ion transport (APExBIO).
• DMA reduces alanine uptake in hepatocytes, indicating inhibition of secondary active transport mechanisms (APExBIO).
• DMA enables robust inhibition of NHE-mediated pH recovery in mammalian cell lines, outperforming less selective amiloride analogs (Related Article).
• MSN (Moesin) upregulation, a biomarker of endothelial injury, is mechanistically linked to altered ion transport and NHE1 activity in sepsis models (Chen et al. 2021).

Applications, Limits & Misconceptions

Applications: DMA is widely used in cardiovascular disease research to model ischemia-reperfusion injury and cardiac contractile dysfunction. Its precision enables detailed study of intracellular pH regulation, cell volume changes, and sodium ion dynamics in various mammalian cell types. DMA is also applied in hepatocyte ion transport studies and in the dissection of secondary transporter function. The reagent is recommended for research workflows requiring high reproducibility and selectivity [Related Guide]—this article updates those protocols with recent biomarker integration and benchmarking data.

Common Pitfalls or Misconceptions

• DMA is not a pan-NHE inhibitor: Its activity is minimal against NHE4, NHE5, and NHE7, so alternative inhibitors are required to probe these isoforms.
• Not suitable for diagnostic or therapeutic use: DMA is intended for research purposes only and is not approved for clinical applications.
• Solutions are unstable long-term: Freshly prepared solutions are required, as DMA loses activity if stored in solution for extended periods.
• Solubility limitations: DMA is soluble up to 30 mg/ml in DMSO or DMF; exceeding this may result in precipitation.
• Ion transport effects are context-dependent: DMA’s effects on transporters other than NHE1-3 (e.g., sodium-potassium ATPase) occur at higher concentrations, so dose selection is critical.

Workflow Integration & Parameters

DMA (SKU C3505) is supplied as a crystalline hydrochloride salt by APExBIO. It should be stored at -20°C and protected from moisture. Prepare solutions immediately before use to maintain full inhibitory activity. Typical working concentrations range from 0.01 to 10 μM for NHE1 inhibition, depending on cell line and assay format. DMA is compatible with pH-sensitive fluorescent dyes, ion-selective electrodes, and cell viability/proliferation assays. For advanced experimental design, refer to the cell assay optimization guide, which this article extends with additional benchmarking and sepsis relevance.

For mechanistic studies, DMA can be used in combination with inhibitors of other ion transporters to delineate pathway specificity. Researchers modeling sepsis or endothelial injury should consider integrating DMA into protocols involving MSN (Moesin) biomarker analysis, as described in recent translational research [Translational Perspective].

Conclusion & Outlook

5-(N,N-dimethyl)-Amiloride (hydrochloride) from APExBIO provides unmatched selectivity and potency for NHE1 inhibition, enabling robust experimental dissection of intracellular pH regulation, sodium transport, and cardiovascular injury mechanisms. Its benchmarked performance and compatibility with modern cell-based assays make it an essential reagent for high-impact research. Future directions include integration with biomarker discovery workflows and advanced ion transport models. For detailed specifications, refer to the product page.